MREO
Mereo BioPharma
MREO
MREO
16 hedge funds and large institutions have $5.21M invested in Mereo BioPharma in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$89.3K | |
| 2 | +$39.1K | |
| 3 | +$3.14K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.72K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.2K |
Top Sellers
| 1 | -$88.8K | |
| 2 | -$37K | |
| 3 | -$26K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$20K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$3K |